Filter
642
Text search:
Post-exposure
prophylaxis
Featured
82
222
Language
Document type
399
121
48
27
21
10
9
3
2
1
1
Countries / Regions
37
30
25
24
23
20
19
17
17
15
13
11
11
11
10
8
8
8
7
6
5
5
5
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
312
66
47
33
30
8
5
Toolboxes
107
35
20
17
17
14
14
14
13
11
9
7
5
5
4
4
3
3
2
2
2
1
Rabies is a viral infection of wild and domestic mammals, transmitted to humans by the saliva of infected animals through bites, scratches or licks on broken skin or mucous membranes.
In endemic areas (Africa and Asia), 99% of cases are due to dog bites and 40% of cases are children under 15 years
...
The World Health Organization recently redefined leprosy elimination as a phased process, with the first milestone being the
interruption of transmission, achieved when no new child cases (defined as younger than 15 years) are reported for five consecutive years.
In Pakistan, the well-functioning
...
Accessed on 20.08.2022#
Actualización en Profilaxis Post Exposición (PPE) en Niños, Niñas y Adolescentes
Report the Abuse fact sheet
La Profilaxis Post-Exposición para el VIH (PEP) constituye una herramienta de prevención que consiste en el uso de medicamentos antiretrovirales para reducir el riesgo de infección luego de situaciones de potencial exposición del virus. Su incorporación está recomendada por la Organización Mu
...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely
...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends
...
This PrEP Implementation SOP will serve as a more detailed guide for NCHADS, partners and providers at FHC, NGO clinics and medically supervised CBO DICs
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
Proyecto VIH/SIDA/ITS en 6 Regiones Sanitarias del Paraguay
